'Plug-and-play' CAR T technology adapts as cancer changes

Researchers from City of Hope person developed a caller "plug-and-play" exertion that adds engineered molecules to chimeric antigen receptor (CAR) T cells aft treatment, allowing scientists to amended power the cells and redirect them to onslaught antithetic types of cancer. Published successful Cancer Immunology Research, the preclinical survey offers a much flexible mode to assistance CAR T cells support gait with mutating tumors.